UNSPSC 51386301: Meseclazone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C11H10ClNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 51KFT71THG, chemically known as 7-chloro-3,3a-dihydro-2-methyl-2h,9h-isoxazolo(3,2-b)(1,3)benzoxazin-9-one but generally known as meseclazone, which bears US NIH Compound Identifier 34445. European Medicines Agency schedules Meseclazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08783MIG.

UNSPSC 51386301 Meseclazone, a Commodity code, does not align with the state and local procurement activity recently tagged under it. The single recent opportunity on record — Seminole County, Florida's IFB for naloxone and drug deactivation systems — bears no relationship to meseclazone, a pharmaceutical compound used in veterinary and human medicine. The mismatch suggests either a data-entry error in the county's procurement tagging or that meseclazone procurement under this code is not occurring in the state and local market at present.

The source contains no evidence of active state and local government demand for meseclazone itself. The Seminole County solicitation, posted June 30, 2026 with a response deadline of July 26, 2023, procures opioid-reversal and controlled-substance disposal products — distinct from the meseclazone commodity designation. Without additional recent opportunities correctly tagged to this code, no meaningful characterization of issuing-body mix, geographic spread, or representative scope is possible. State and local procurement activity under UNSPSC 51386301 Meseclazone does not surface in the available record.